Notably, Nec-1 treatment significantly decreased the higher coefficient of colocalization of RIPK1 and GFAP in striata of PD mice, implying that RIPK1 is activated in the PD brain and may be involved in regulating disease-related astrocyte function. Here, GFAP is linked to Parkinson disease.